We evaluated the feasibility of 5-aminolevulinic acid (5-ALA)-mediated photodynamic diagnosis (PDD) in the biopsy 14 for primary central nervous system lymphoma (PCNSL). 5-ALA (20 mg/kg) was administered orally 4 hours 15 preoperatively. Forty-one biopsies obtained under PDD in 47 consecutive biopsies (46 patients) that were finally 16 pathologically diagnosed as PCNSL were evaluated. Positive fluorescence was observed in 34 of those 41 biopsies 17 (82.9%). An intraoperative pathological diagnosis (IOD) of suspected PCNSL was made in 21 of the biopsies with 18 positive fluorescence (61.8%). However, the 8 IODs in the remaining 13 biopsies (23.5%) were not correct (atypical cell, 19 4; high-grade glioma, 1; gliosis, 1; unremarkable, 2). In those 8 biopsies, PCNSL was confirmed by the final pathological 20 diagnosis. There was no difference in the mean Mib-1 labeling index between the biopsies with positive fluorescence 21 (86.5%) and those without (90.0%). IOD was not performed in 6 biopsies; however, 5 of those biopsies (83.3%) showed 22 positive fluorescence and were finally pathologically diagnosed as PCNSL. Use of PDD in biopsies for patients with 23 suspected PCNSL is a reliable way of obtaining specimens of adequate quality for the final pathological diagnosis and 24 may lead to improved diagnostic yield in the biopsy of PCNSL. 25 26 27 28 Keywords: primary central nervous system lymphoma, 5-aminolevulinic acid, endoscopic biopsy, photodynamic 29 diagnosis 30 31 103 41 biopsies obtained under PDD. Five of them (83.3%) showed positive fluorescence and were diagnosed as PCNSL at 104 the final pathologic diagnosis. Fluorescence was not observed in 7 of the 41 biopsies conducted under PDD (17.1%). In 3 105 of those (42.9%), an IOD of suspected PCNSL was made. In the remaining 4 biopsies (57.1%), the IOD was either 106 incorrect (atypical cell, 1; high-grade glioma, 1; necrosis, 1) or not performed (1). There was no difference in the mean 107 7 7 Mib-1 labeling index between the tumor cells with positive fluorescence (86.5%) and those without (90.0%). 108 109 Discussion 110 5-ALA-mediated PDD has often been performed with tumor biopsy, and such a combination is advantageous 111 in facilitating diagnostic yield by distinguishing tumor-containing samples by use of fluorescence [7]. Although several 112 pathologic types of brain tumor were reported in the literature on fluorescence-assisted biopsy, it is difficult to estimate 113 the rate of positive fluorescence in PDD of PCNSL because of the limited number of such published cases. To the best of 114 our knowledge, only 11 PCNSL cases with biopsy or resection conducted under 5-ALA-mediated PDD have been 115 reported, and all of those showed positive fluorescence [4, 8-10]. Moriuchi and colleagues reported stereotactic biopsy 116 conducted under PDD for a PCNSL of the thalamus and for a pontine glioma to confirm the target tumor tissues [9]. 117 Grossman and colleagues reported positive fluorescence in PCNSL of the fourth ventricular floor [8]. Eljamel and 118 colleagues reported 2 PCNSL with positive fluorescence [11]. Widhalm and colleagues found that all 16 samples taken 119 from 7 PCNSL cases showed positive fluorescence (strong, 14: weak, 2) [10]. In the present study, positive fluorescence 120
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Photodynamic diagnosis (PDD) in neurosurgery for several types of brain tumors was first described by Moore and 33 colleagues [1] . While the PDD in their study was predominantly mediated by fluorescein, 5-aminolevulinic acid (5-ALA) 34 has been successfully applied for fluorescence-guided tumor resections, leading to the widespread use of this technique 35 in the neurosurgical field worldwide. In 5-ALA-mediated PDD, fluorescence is obtained on the basis of accumulation of 36 protoporphyrin IX (PpIX) in malignant tumor cells following oral administration of 5-ALA as a precursor of heme 37 biosynthesis. Proof of the benefit of 5-ALA-mediated PDD for glioblastoma was obtained by a randomized controlled 38 multicenter phase-III trial conducted by Stummer and colleagues, which showed statistically significant improvement in 39 the extent of tumor removal and 6-month progression-free survival after surgery, although the overall survival was not 40 prolonged [2] . 41 42 PDD using 5-ALA has also been applied in surgery for brain tumors other than glioblastomas, such as meningiomas, 43 pituitary adenomas, and metastatic tumors [3-5]. For instance, 94.0% (31 of 33) of meningiomas showed positive 44 fluorescence [3]. The sensitivity of 5-ALA-mediated PDD for pituitary adenoma was 80.8% (21/26) in endoscopy with 45 photodiagnostic filters and 95.5% (21/22) in the PpIX spectroscopy optical biopsy system [4] . Fifty-two of 78 pediatric 46 brain tumors (66.7%) showed positive fluorescence; they included high-grade gliomas (HGG), ependymomas, primitive 47 neuroectodermal tumors (PNETs), gangliogliomas, medulloblastomas, and pilocytic astrocytomas [6].
49
Biopsy and subsequent pathologic confirmation are undertaken as the standard of care for PCNSL such as systemic 50 4 4 chemotherapy and radiotherapy. However, only a few PCNSL cases have previously been reported (a portion of a patient 51 cohort who received 5-ALA-mediated PDD), and the role and impact of PDD for PCNSL have not been established.
52
Minimizing the extent of surgery is essential for reducing the risks during brain tumor biopsies, while samples that are 
73
with a removable inner tube (Neuroport; Olympus, Tokyo, Japan) was inserted through the burr hole until the front of the 74 target lesion was under the control of the navigation system; the lesion was further observed with a rigid endoscope 75 (EndoArm; Olympus). In the endoscopic biopsies, the lesion was gradually removed [7] . Open biopsy was also 76 performed under navigation-guided planning. After the skin incision and small craniotomy, a 12-Fr catheter tube was 77 inserted from the brain surface towards the target, and a 1.5-to 2-cm corticotomy, performed. In the stereotactic biopsies, 78 a Komai stereotactic frame or frameless neuronavigation was used, and the first target was set at the central or 
